Cargando…

Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: a clue to interpret different chances of relapse after clinical remission?

OBJECTIVE: To define the synovial characteristics of patients with rheumatoid arthritis (RA) and psoriatic arthritis (PsA) in clinical and ultrasound remission achieved by combination therapy with methotrexate (MTX) and tumour necrosis factor (TNF) blockers. METHODS: Patients with RA in remission (n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alivernini, Stefano, Tolusso, Barbara, Petricca, Luca, Bui, Laura, Di Sante, Gabriele, Peluso, Giusy, Benvenuto, Roberta, Fedele, Anna Laura, Federico, Franco, Ferraccioli, Gianfranco, Gremese, Elisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Clinical and Epidemiological Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530352/ https://www.ncbi.nlm.nih.gov/pubmed/28119289 http://dx.doi.org/10.1136/annrheumdis-2016-210424

Ejemplares similares

Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission
por: Alivernini, Stefano, et al.
Publicado: (2016)

Very early rheumatoid arthritis is the major predictor of major outcomes: clinical ACR remission and radiographic non-progression
por: Bosello, Silvia, et al.
Publicado: (2011)

Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis
por: Alivernini, Stefano, et al.
Publicado: (2019)

Ultrasound assessment as predictor of disease relapse in children and adults with arthritis in clinical stable remission: new findings but still unmet needs
por: Gremese, Elisa, et al.
Publicado: (2018)

Synovial Predictors of Differentiation to Definite Arthritis in Patients With Seronegative Undifferentiated Peripheral Inflammatory Arthritis: microRNA Signature, Histological, and Ultrasound Features
por: Alivernini, Stefano, et al.
Publicado: (2018)

Overweight/obesity affects histological features and inflammatory gene signature of synovial membrane of Rheumatoid Arthritis
por: Alivernini, Stefano, et al.
Publicado: (2019)

Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis
por: Di Sante, Gabriele, et al.
Publicado: (2015)

Chemerin and PEDF Are Metaflammation-Related Biomarkers of Disease Activity and Obesity in Rheumatoid Arthritis
por: Tolusso, Barbara, et al.
Publicado: (2018)

ACR70-disease activity score remission achievement from switches between all the available biological agents in rheumatoid arthritis: a systematic review of the literature
por: Alivernini, Stefano, et al.
Publicado: (2009)

Inclusion of Synovial Tissue–Derived Characteristics in a Nomogram for the Prediction of Treatment Response in Treatment‐Naive Rheumatoid Arthritis Patients
por: Alivernini, Stefano, et al.
Publicado: (2021)

MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis
por: Alivernini, Stefano, et al.
Publicado: (2016)

Do we need to apply a T2T strategy even in ACPA-negative early rheumatoid arthritis? YES
por: Ferraccioli, Gianfranco, et al.
Publicado: (2016)

Systemic Bone Density at Disease Onset Is Associated With Joint Erosion Progression in Early Naive to Treatment Rheumatoid Arthritis: A Prospective 12-Month Follow-Up Open-Label Study
por: Bruno, Dario, et al.
Publicado: (2021)

Peripheral blood CD4(pos)CD25(pos)FoxP3(pos) cells and inflammatory cytokines as biomarkers of response in rheumatoid arthritis patients treated with CTLA4-Ig
por: Elisa, Gremese, et al.
Publicado: (2022)

Correction: Peripheral blood CD4(pos)CD25(pos)FoxP3(pos) cells and inflammatory cytokines as biomarkers of response in rheumatoid arthritis patients treated with CTLA4-Ig
por: Gremese, Elisa, et al.
Publicado: (2022)

The Role of High-Mobility Group Box-1 and Its Crosstalk with Microbiome in Rheumatoid Arthritis
por: Biscetti, Federico, et al.
Publicado: (2017)

Driving chronicity in rheumatoid arthritis: perpetuating role of myeloid cells
por: Alivernini, S., et al.
Publicado: (2018)

The forgotten key players in rheumatoid arthritis: IL-8 and IL-17 – Unmet needs and therapeutic perspectives
por: Gremese, Elisa, et al.
Publicado: (2023)

Demographic and Clinical Factors Associated with Patient-Reported Remission in Psoriatic Arthritis
por: Gondo, George, et al.
Publicado: (2022)

Could we use a lower dose of rituximab to treat rheumatoid arthritis in clinical practice: pros and cons?
por: Ferraccioli, Gianfranco, et al.
Publicado: (2016)

Paradoxical arthritis occurring during anti-TNF in patients with inflammatory bowel disease: histological and immunological features of a complex synovitis
por: Alivernini, Stefano, et al.
Publicado: (2018)

Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study
por: Gremese, Elisa, et al.
Publicado: (2013)

Remission in psoriatic arthritis: is it possible and how can it be predicted?
por: Saber, Tajvur P, et al.
Publicado: (2010)

Ultrasound remission in patients with rheumatoid arthritis in clinical remission
por: Fakhfakh, Rym, et al.
Publicado: (2021)

Haemophilus parasuis (Glaesserella parasuis) as a Potential Driver of Molecular Mimicry and Inflammation in Rheumatoid Arthritis
por: Di Sante, Gabriele, et al.
Publicado: (2021)

Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients
por: Lubrano, Ennio, et al.
Publicado: (2019)

Memory B cell subsets and plasmablasts are lower in early than in long-standing Rheumatoid Arthritis
por: Fedele, Anna Laura, et al.
Publicado: (2014)

Depression and Endothelial Dysfunction in Psoriatic Arthritis: Is There Any Possible Relationship?
por: De Lorenzis, Enrico, et al.
Publicado: (2021)

MicroRNA-155—at the Critical Interface of Innate and Adaptive Immunity in Arthritis
por: Alivernini, Stefano, et al.
Publicado: (2018)

Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue
por: Totaro, Michele Ciro, et al.
Publicado: (2013)

JAK inhibition by methotrexate (and csDMARDs) may explain clinical efficacy as monotherapy and combination therapy
por: Gremese, Elisa, et al.
Publicado: (2019)

PTPN22 1858C>T Polymorphism Distribution in Europe and Association with Rheumatoid Arthritis: Case-Control Study and Meta-Analysis
por: Totaro, Michele Ciro, et al.
Publicado: (2011)

Remission in Rheumatoid Arthritis
por: Shammas, Rania M., et al.
Publicado: (2010)

Remission of Psoriasis and Psoriatic Arthritis During Bevacizumab Therapy for Renal Cell Cancer
por: Datta-Mitra, Ananaya, et al.
Publicado: (2014)

MRI evaluation of clinical remission in juvenile idiopathic arthritis
por: van Veenendaal, M, et al.
Publicado: (2011)

Sustained rheumatoid arthritis remission is uncommon in clinical practice
por: Prince, Femke HM, et al.
Publicado: (2012)

Rheumatoid Arthritis: Defining Clinical and Ultrasound Deep Remission
por: Hèctor, Corominas, et al.
Publicado: (2020)

Remission of psoriasis and psoriatic arthritis during bevacizumab therapy for renal cell cancer: Erratum
por: Lahiri, Koushik
Publicado: (2015)

A Machine Learning Approach to Predict Remission in Patients With Psoriatic Arthritis on Treatment With Secukinumab
por: Venerito, Vincenzo, et al.
Publicado: (2022)

Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis
por: Tolusso, B, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_82jef3e3aulrojpltosjk1ck20